Protalix Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $18,218 | $17,959 | $13,474 | $3,748 |
Gross Profit | 14,332 | 9,584 | 4,018 | 1,146 |
EBITDA | 7,656 | 4,471 | -1,586 | -4,021 |
EBIT | 7,322 | 4,142 | -1,905 | -4,343 |
Net Income | 6,494 | 3,236 | -2,203 | -4,595 |
Net Change In Cash | 18,218 | 17,959 | 13,474 | 3,748 |
Free Cash Flow | 3,566 | 4,018 | -3,782 | 3,589 |
Cash | 19,760 | 27,409 | 23,399 | 27,209 |
Basic Shares | 73,549 | 81,217 | 73,308 | 73,036 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $53,399 | $65,494 | $47,638 | $38,350 |
Gross Profit | 29,080 | 42,512 | 28,046 | 22,001 |
EBITDA | 6,520 | 11,651 | -10,782 | -18,943 |
EBIT | 5,216 | 10,460 | -11,868 | -20,061 |
Net Income | 2,932 | 8,312 | -14,927 | -33,985 |
Net Change In Cash | 53,399 | 65,494 | 47,638 | 38,350 |
Free Cash Flow | 7,392 | -2,467 | -25,628 | -11,744 |
Cash | 19,760 | 23,634 | 17,111 | 38,985 |
Basic Shares | 81,057 | 82,424 | 48,472 | 44,140 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.09 |
2024-09-30 | $0.03 |
2024-06-30 | -$0.03 |
2024-03-31 | -$0.06 |
